These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2322591

  • 1. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.
    Veldscholte J, Voorhorst-Ogink MM, Bolt-de Vries J, van Rooij HC, Trapman J, Mulder E.
    Biochim Biophys Acta; 1990 Apr 09; 1052(1):187-94. PubMed ID: 2322591
    [Abstract] [Full Text] [Related]

  • 2. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
    Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ.
    Prostate; 1992 Apr 09; 21(1):63-73. PubMed ID: 1379363
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
    Schuurmans AL, Bolt J, Mulder E.
    Urol Int; 1989 Apr 09; 44(2):71-6. PubMed ID: 2728128
    [Abstract] [Full Text] [Related]

  • 4. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.
    Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, Trapman J, Brinkmann AO, Mulder E.
    Biochem Biophys Res Commun; 1990 Dec 14; 173(2):534-40. PubMed ID: 2260966
    [Abstract] [Full Text] [Related]

  • 5. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
    Schuurmans AL, Bolt J, Voorhorst MM, Blankenstein RA, Mulder E.
    Int J Cancer; 1988 Dec 15; 42(6):917-22. PubMed ID: 3263955
    [Abstract] [Full Text] [Related]

  • 6. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
    Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J, Brinkmann AO, Mulder E.
    J Steroid Biochem Mol Biol; 1992 Mar 15; 41(3-8):665-9. PubMed ID: 1562539
    [Abstract] [Full Text] [Related]

  • 7. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
    Beilin J, Ball EM, Favaloro JM, Zajac JD.
    J Mol Endocrinol; 2000 Aug 15; 25(1):85-96. PubMed ID: 10915221
    [Abstract] [Full Text] [Related]

  • 8. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM, de Boer W, Mulder E.
    Prostate; 1986 Aug 15; 9(3):247-59. PubMed ID: 2946029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Binding of progestagens to receptor proteins in MCF-7 cells.
    Bergink EW, van Meel F, Turpijn EW, van der Vies J.
    J Steroid Biochem; 1983 Nov 15; 19(5):1563-70. PubMed ID: 6645495
    [Abstract] [Full Text] [Related]

  • 15. Stabilization of androgen receptor by nonandrogenic steroids.
    Nemoto T, Ohara-Nemoto Y, Sato M, Ota M.
    Biochem Int; 1986 May 15; 12(5):701-5. PubMed ID: 3488063
    [Abstract] [Full Text] [Related]

  • 16. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.
    Castagnetta LA, Miceli MD, Sorci CM, Pfeffer U, Farruggio R, Oliveri G, Calabrò M, Carruba G.
    Endocrinology; 1995 May 15; 136(5):2309-19. PubMed ID: 7536668
    [Abstract] [Full Text] [Related]

  • 17. Threonine on amino acid position 868 in the human androgen receptor is essential for androgen binding specificity and functional activity.
    Ris-Stalpers C, Verleun-Mooijman MC, Trapman J, Brinkmann AO.
    Biochem Biophys Res Commun; 1993 Oct 15; 196(1):173-80. PubMed ID: 8216289
    [Abstract] [Full Text] [Related]

  • 18. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G.
    Prostate; 2013 Sep 15; 73(13):1378-90. PubMed ID: 23728788
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.